ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome
EMBO Molecular Medicine · 11.10.2023 · 15 (10)
DOI: 10.15252/emmm.202318142 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 07.09.2023. Verfasst von Lola Rodríguez-Ruiz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departmento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, Murcia, Spain. Hauptthemen laut MEDLINE: Hematopoiesis, Inflammasomes, Zebrafish Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejería de Salud CARM, Diamond-Blackfan Anemia Foundation, Fundación Séneca (FS).
Abstract (Originalsprache)
Chronic inflammatory diseases are associated with hematopoietic lineage bias, including neutrophilia and anemia. We have recently identified that the canonical inflammasome mediates the cleavage of the master erythroid transcription factor GATA1 in hematopoietic stem and progenitor cells (HSPCs). We report here that genetic inhibition of Nlrp1 resulted in reduced number of neutrophils and increased erythrocyte counts in zebrafish larvae. We also found that the NLRP1 inflammasome in human cells was inhibited by LRRFIP1 and FLII, independently of DPP9, and both inhibitors regulated hematopoiesis. Mechanistically, erythroid differentiation resulted in ribosomal stress‐induced activation of the ZAKα/P38 kinase axis which, in turn, phosphorylated and promoted the assembly of NLRP1 in both zebrafish and human. Finally, inhibition of Zaka with the FDA/EMA‐approved drug Nilotinib alleviated neutrophilia in a zebrafish model of neutrophilic inflammation and promoted erythroid differentiation and GATA1 accumulation in K562 cells. In conclusion, our results reveal that the NLRP1 inflammasome regulates hematopoiesis and pave the way to develop novel therapeutic strategies for the treatment of hematopoietic alterations associated with chronic inflammatory and rare diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departmento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, Murcia, Spain.
- Instituto Murciano de Investigación Biosanitaria (IMIB)-Pascual Parrilla, Murcia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
- Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.
- Departamento de Medicina y Unidad de Terapia Celular y Trasplante Hematopoyético, Facultad de Medicina, Universidad de Murcia, Murcia, Spain.
ORCID-Profile: Lola Rodríguez-Ruiz, Juan M Lozano-Gil, Elena Naranjo-Sánchez, Elena Martínez-Balsalobre, Christophe Lachaud, Diana García-Moreno, María L Cayuela, Sylwia D Tyrkalska, Victoriano Mulero
Förderung
- Consejería de Salud CARM
- Diamond-Blackfan Anemia Foundation
- Fundación Séneca (FS)
- MEC ¦ Instituto de Salud Carlos III (ISCIII)
- Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)
- Ministerio de Universidades (MU)
- Diamond‐Blackfan Anemia Foundation
Zitieren
APA
Rodríguez-Ruiz, L., Lozano-Gil, J. M., Naranjo-Sánchez, E., Martínez-Balsalobre, E., Martínez-López, A., Lachaud, C., Blanquer, M., Phung, T. K., García-Moreno, D., Cayuela, M. L., Tyrkalska, S. D., Pérez-Oliva, A. B., & Mulero, V. (2023). ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome. EMBO Molecular Medicine, 15(10). https://doi.org/10.15252/emmm.202318142
Vancouver
Rodríguez-Ruiz L, Lozano-Gil JM, Naranjo-Sánchez E, Martínez-Balsalobre E, Martínez-López A, Lachaud C, et al. ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome. EMBO Molecular Medicine. 2023;15(10). doi:10.15252/emmm.202318142
BibTeX
@article{RodrguezRuiz2023,
author = {Rodríguez-Ruiz, Lola and Lozano-Gil, Juan M and Naranjo-Sánchez, Elena and Martínez-Balsalobre, Elena and Martínez-López, Alicia and Lachaud, Christophe and Blanquer, Miguel and Phung, Toan K and García-Moreno, Diana and Cayuela, María L and Tyrkalska, Sylwia D and Pérez-Oliva, Ana B and Mulero, Victoriano},
title = {ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome},
journal = {EMBO Molecular Medicine},
year = {2023},
volume = {15},
number = {10},
doi = {10.15252/emmm.202318142}
}
EUVIMED